Advances in lung cancer surgery: the role of segmentectomy in early–stage management

References

• Detterbeck FC, Blasberg JD, Woodard GA, et al. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 1: a guide to decision-making. J Thorac Dis. 2022 Jun;14(6):2340–2356.
   PubMed Web of Science ®Google Scholar
• Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann Thorac Surg. 1995 Sep;60(3):615–622. discussion 622-3. doi: 10.1016/0003-4975(95)00537-U
   PubMed Web of Science ®Google Scholar
• Bedetti B, Bertolaccini L, Rocco R, et al. Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis. 2017 Jun;9(6):1615–1623.
   PubMed Web of Science ®Google Scholar
• Altorki N, Wang X, Kozono D, et al. Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer. N Engl J Med. 2023 Feb 9;388(6):489–498. doi: 10.1056/NEJMoa2212083
   PubMed Web of Science ®Google Scholar
• Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022 Apr 23;399(10335):1607–1617. doi: 10.1016/S0140-6736(21)02333-3
   PubMed Web of Science ®Google Scholar
• Lee B, Mynard N, Nasar A, et al. Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: results from a randomized trial. J Thorac Cardiovasc Surg. 2023 Jan;165(1):327–334 e2. doi: 10.1016/j.jtcvs.2022.07.017
   PubMed Web of Science ®Google Scholar
• Behinaein P, Treffalls J, Hutchings H, et al. The role of sublobar resection for the surgical treatment of non-small cell lung cancer. Curr Oncol. 2023 Jul 22;30(7):7019–7030. doi: 10.3390/curroncol30070509
   PubMed Web of Science ®Google Scholar
• Bertolaccini L, Prisciandaro E, Bardoni C, et al. Minimally invasive anatomical segmentectomy versus Lobectomy in stage IA non-small cell lung cancer: a systematic review and meta-analysis. Cancers (Basel). 2022 Dec 14;14(24). doi: 10.3390/cancers14246157
   Web of Science ®Google Scholar
• Meldola PF, Toth OAS, Schnorrenberger E, et al. Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled trials. Surg Oncol. 2023 Dec;51:101995.
   PubMed Web of Science ®Google Scholar
• Bertolaccini L, Spaggiari L. Is it time to cross the pillars of evidence in favor of segmentectomies in early-stage non-small cell lung cancer? Cancers (Basel). 2023;15(7):1993. doi: 10.3390/cancers15071993
   PubMed Web of Science ®Google Scholar
• Forde PM, Spicer J, Lu S, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022 May 26;386(21):1973–1985. doi: 10.1056/NEJMoa2202170
   PubMed Web of Science ®Google Scholar
• Felip E, Altorki N, Zhou C, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet. 2021 Oct 9;398(10308):1344–1357. doi: 10.1016/S0140-6736(21)02098-5
   PubMed Web of Science ®Google Scholar
• Shi Y, Wu S, Ma S, et al. Comparison between wedge resection and lobectomy/segmentectomy for early-stage non-small cell lung cancer: a bayesian meta-analysis and systematic review. Ann Surg Oncol. 2022 Mar;29(3):1868–1879.
   PubMed Web of Science ®Google Scholar
• Fong KY, Chan YH, Chia CML, et al. Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer. Updates Surg. 2023 Dec;75(8):2343–2354.
   PubMed Web of Science ®Google Scholar
• Kocak Uzel E, Bagci Kilic M, Morcali H, et al. Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer. Sci Rep. 2023 Jun 27;13(1):10384.
   PubMed Web of Science ®Google Scholar
• Bertolaccini L, Terzi A, Ricchetti F, et al. Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future? Ann Transl Med. 2015 Feb;3(2):25.
   PubMedGoogle Scholar
• Lee BE, Altorki N. Sub-lobar resection: the new standard of care for early-stage lung cancer. Cancers (Basel). 2023 May 25;15(11). doi: 10.3390/cancers15112914
   Web of Science ®Google Scholar
• Zaraca F, Kirschbaum A, Pipitone MD, et al. Prospective randomized study on the efficacy of three-dimensional reconstructions of bronchovascular structures on preoperative chest CT scan in patients who are candidates for pulmonary segmentectomy surgery: the PATCHES (prospective rAndomized sTudy efficaCy of tHree-dimensional rEconstructions segmentecomy) study protocol. Trials. 2023 Sep 16;24(1):594.
   PubMed Web of Science ®Google Scholar
• Zaraca F, Kirschbaum A, Pipitone MD, et al. Correction: prospective randomized study on the efficacy of three-dimensional reconstructions of bronchovascular structures on preoperative chest CT scan in patients who are candidates for pulmonary segmentectomy surgery: the PATCHES (prospective rAndomized sTudy efficaCy of tHree-dimensional rEconstructions segmentecomy) study protocol. Trials. 2023 Oct 3;24(1):629.
   PubMed Web of Science ®Google Scholar
• Galanis M, Leivaditis V, Gioutsos K, et al. Segmentectomy versus lobectomy. Which factors are decisive for an optimal oncological outcome? Kardiochir Torakochirurgia Pol. 2023 Sep;20(3):179–186.
   PubMedGoogle Scholar
• Detterbeck FC, Lewis SZ, Diekemper R, et al. Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):7S–37S.
   PubMed Web of Science ®Google Scholar
• De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014 May;45(5):787–98.
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Aisner DL, et al. NCCN guidelines(R) insights: non-small cell lung cancer, version 2.2023. J Natl Compr Canc Netw. 2023 Apr;21(4):340–350.
   PubMedGoogle Scholar